Status:
COMPLETED
Eosinophil Indices in Patients With Acute Heart Failure
Lead Sponsor:
Giresun University
Conditions:
Acute Heart Failure
Reduced Systolic Function
Eligibility:
All Genders
18-90 years
Brief Summary
All consecutive patients admitted to the intensive care unit (ICU) with ADHF between January 2017 and December 2021 were enrolled in this retrospective study. All-cause mortality and MACE were assesse...
Detailed Description
All consecutive patients admitted to the intensive care unit (ICU) with ADHF and reduced EF between January 2017 and December 2021 were enrolled in this retrospective study. HFrEF was defined as havin...
Eligibility Criteria
Inclusion
- patients who admitted to the intensive care unit (ICU) with Acute Decompensated Heart Failure and reduced Ejection Fraction (\<%40)
Exclusion
- Patients with an LVEF \>40%, NYHA Class I and II subjects, those with advanced liver, kidney diseases or malignancies, patients in whom life expectancy was extremely short and patients with autoimmune, allergic, or infectious diseases
Key Trial Info
Start Date :
January 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 5 2022
Estimated Enrollment :
395 Patients enrolled
Trial Details
Trial ID
NCT05410990
Start Date
January 2 2017
End Date
April 5 2022
Last Update
June 8 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.